NUCALA sol inj 100 mg/ml stylo prérempli 3 pce

7680673500026 CH-67350 R03DX09
NUCALA sol inj 100 mg/ml stylo prérempli 3 pce
NUCALA sol inj 100 mg/ml stylo prérempli 3 pce
NUCALA sol inj 100 mg/ml stylo prérempli 3 pce
1 / 3
google

Details

Product number
-
CPT
-
Packaging group
-
Unit
-

Articles (1)

Nucala 100 mg/mL, Injektionslösung im Fertigpen
Injektionslösung im Fertigpen
3 x 1
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
02/03/2026
Patient information leaflet
Français
02/03/2026
Patient information leaflet
Italien
02/03/2026
Professional SmPC
Allemand
02/03/2026
Professional SmPC
Français
02/03/2026
Professional SmPC
Italien
02/03/2026

Detailed composition

Substance Quantity Type Category
mepolizumabum
100.0 MG Substance Wirkstoff (Principe actif)
saccharum
- Substance HNIDK
dinatrii phosphas heptahydricus
- Substance HNIDK
acidum citricum monohydricum
- Substance HNIDK
polysorbatum 80
- Substance HNIDK
dinatrii edetas
- Substance HNIDK
aqua ad iniectabile
- Substance HNIDK
natrium
0.72 MG Substance HBESI

Authorization holder

GlaxoSmithKline AG

6340 Baar

Authorization information

Swissmedic authorization number
67350
Drug name
Nucala, Injektionslösung im Fertigpen
Galenic form
INLFP
ATC Code
R03DX09
Authorization status
Z
Dispensation category
B
First authorization
13/02/2020
Authorization expiration date
31/12/9999
IT number
03.04.5.
Domain
Human medicine
Field of application
Eosinophiles Asthma, EGPA, CRSwNP, HES, COPD

Packaging details

Description (FR)
NUCALA sol inj 100 mg/ml stylo prérempli 3 pce
Description (DE)
NUCALA Inj Lös 100 mg/ml Fertigpen 3 Stk
Market launch
13/02/2020
Narcotic (BTM)
No

Other packaging sizes

NUCALA sol inj 100 mg/ml stylo prérempli
1 INJ
View
Buy us a coffee Explore the data